{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:03:45Z","timestamp":1790906625164,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,27]]},"DOI":"10.1097\/tp.0b013e31819b3d72","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T17:06:32Z","timestamp":1242925592000},"page":"896-906","source":"Crossref","is-referenced-by-count":92,"title":["Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients"],"prefix":"10.1097","volume":"87","author":[{"given":"Meindert J.","family":"Crop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander S.","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan N.M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.J.","family":"Alwayn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Weimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Hoogduijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells.","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"R3-17-20210129","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses.","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells.","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","article-title":"Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves.","volume":"12","author":"Batten","year":"2006","journal-title":"Tissue Eng"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2128","article-title":"Cell therapy for autoimmune diseases.","volume":"9","author":"Dazzi","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.","volume":"81","author":"Inoue","year":"2006","journal-title":"Transplantation"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells.","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2005.08.039","article-title":"Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.","volume":"11","author":"Maccario","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/scd.2006.0110","article-title":"Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities.","volume":"16","author":"Hoogduijn","year":"2007","journal-title":"Stem Cells Dev"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-6143.2008.02450.x","article-title":"Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart.","volume":"9","author":"Hoogduijn","year":"2008","journal-title":"Am J Transplant"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression.","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J Biomed Sci"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"R20-17-20210129","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"R21-17-20210129","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype.","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells.","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"R23-17-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions.","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"R24-17-20210129","first-page":"S2","article-title":"Sequential analysis of CD4+CD25bright+ FoxP3+ T-cells in renal allograft patients reveals no intrinsic defect in their regulatory capacity [abstract].","volume":"7","author":"Hendrikx","year":"2007","journal-title":"Am J Transplant"},{"key":"R25-17-20210129","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.179.7.4901","article-title":"Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.","volume":"179","author":"Bestard","year":"2007","journal-title":"J Immunol"},{"key":"R26-17-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol"},{"key":"R27-17-20210129","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1634\/stemcells.2007-0068","article-title":"Human mesenchymal stem cells promote survival of T cells in a quiescent state.","volume":"25","author":"Benvenuto","year":"2007","journal-title":"Stem Cells"},{"key":"R28-17-20210129","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J Immunol"},{"key":"R29-17-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation.","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"R30-17-20210129","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"R31-17-20210129","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a non-myeloablative setting.","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"R32-17-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-007-0827-9","article-title":"Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.","volume":"300","author":"Sbano","year":"2008","journal-title":"Arch Dermatol Res"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200903270-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:42Z","timestamp":1786038942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200903270-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31819b3d72","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3,27]]}}}